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Abstract
GABA signaling sustains fundamental brain functions, from nervous system development to the synchronization of
population activity and synaptic plasticity. Despite these pivotal features, molecular determinants underscoring the rapid
and cell-autonomous replenishment of the vesicular neurotransmitter GABA and its impact on synaptic plasticity remain
elusive. Here, we show that genetic disruption of the glutamine transporter Slc38a1 in mice hampers GABA synthesis,
modiﬁes synaptic vesicle morphology in GABAergic presynapses and impairs critical period plasticity. We demonstrate that
Slc38a1-mediated glutamine transport regulates vesicular GABA content, induces high-frequency membrane oscillations
and shapes cortical processing and plasticity. Taken together, this work shows that Slc38a1 is not merely a transporter
accumulating glutamine for metabolic purposes, but a key component regulating several neuronal functions.
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Introduction
GABA is the principal inhibitory neurotransmitter in the central
nervous system (CNS) with manifold functions: it regulates
action potential (AP) ﬁring and network synchrony through
perisomatic inhibition and the efﬁcacy and plasticity of
excitation by dendritic inhibition (Klausberger and Somogyi
2008; Huang 2009; Hu et al. 2014). GABA signaling can be either
short-lived and phasic when GABA is released in quanta to act at
synaptic GABAA receptors or long-lasting and tonic upon ambient
extracellular GABA stimulating extra-synaptic receptors (Isaacson
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and Scanziani 2011). In addition, GABA affects developmentally
coded cortical critical period plasticity by modulating interneuron
migration, placement and synaptic wiring (Ben-Ari et al. 2007).
Indeed, at the systems level, GABA signaling underpins learning,
memory, cognition and sensory perception (Buzsaki et al. 2007).
The life-long competence of GABA signaling relies on efﬁcient
local means for neurotransmitter reuptake, replenishment and
release. Considering the prominence of dysfunctional GABA sig-
naling in brain disorders, such as epilepsy, autism, schizophrenia
and anxiety (Soghomonian and Martin 1998; Lewis et al. 2012), it
is surprising that molecular determinants rate-limiting precursor
availability for metabolic replenishment and vesicular ﬁlling and
their impact on inhibitory synaptic plasticity remain elusive.
To describe precursor replenishment, the “glutamate/GABA-
glutamine (GGG) cycle” was proposed decades ago, which suggests
that GABA (and glutamate) upon transport into perisynaptic astro-
glia is ﬁrst converted into glutamine, which is then transported
back into neurons to regenerate GABA as neurotransmitter (Reubi
et al. 1978; Nissen-Meyer and Chaudhry 2013). This is supported by
elucidation of the unconventional kinetics combined with the cell-
speciﬁc localization of a family of amino acid (AA) transporters
(Slc38) (Nissen-Meyer and Chaudhry 2013): system N transporters
Slc38a3 (SN1/SNAT3) and Slc38a5 (SN2/SNAT5) reside on astroglial
membranes and work bi-directionally to supply neurons with glu-
tamine (Chaudhry et al. 1999; Hamdani et al. 2012). Heterologous
expression of the homologous system A transporter (SAT) Slc38a1
(SAT1/SNAT1/SA2) in cultured mammalian cells shows transport
of amino acids with a preference for glutamine (Varoqui et al.
2000; Chaudhry et al. 2002). We have shown that Slc38a1 is
enriched in GABAergic neurons and based on this localization pro-
posed that Slc38a1 could be involved in the replenishment of the
neurotransmitter GABA (Solbu et al. 2010). However, this has been
contested by a number of papers reporting that Slc38a1 occurs
indiscriminately in glutamatergic, GABAergic, cholinergic and
dopaminergic neurons and targeted primarily to their somatoden-
dritic compartments implicating a broader role in general cellular
metabolism (Mackenzie et al. 2003; Conti and Melone 2006). In
addition, the functional signiﬁcance of glutamine in GABA replen-
ishment and the existence of a GGG cycle remain ambiguous since
some studies have shown unchanged neurotransmission upon
pharmacological inhibition of system A transporters, inactivation
of phosphate-activated glutaminase (PAG) and/or removal of
Figure 1. Genetic inactivation of Slc38a1 using the binary Cre/LoxP system and its validation. (A) Schematic drawing of the targeting vector, wild-type allele (Slc38a1wt
(Slc38a1+)), and targeted alleles (Slc38a1ﬂox-Neo, Slc38a1ﬂox, and Slc38a1null (Slc38a1-)). The Slc38a1 targeting vector contained a LoxP site (inserted into intron 4; white
triangles), and a selection cassette (Neomycin) ﬂanked by FRT-sites (black triangles) and a LoxP site (inserted into intron 8). After homologous recombination in ES
cells (Slc38a1ﬂox-Neo locus), ES cells were transected with Flp to excise the selection cassette (Slc38a1ﬂox locus) prior to blastocyst injection. Upon expression of Cre
recombinase, exons 5–8 were excised (Slc38a1 null), generating out of reading frame splicing transcript. The binding site for the 5-end Southern screening probe and
the expected fragment sizes after KpnI digest are indicated. (B) Genotyping of ear biopsies of Slc38a1+/+, Slc38a1+/- (heterozygous) and Slc38a1−/− mice by 3 pairs of
probes gives the expected ampliﬁed fragments (see Supplementary Experimental Procedures). (C) Southern blot analysis of DNA isolated from liver of Slc38a1+/+,
Slc38a1+/−, and Slc38a1−/− mice. DNA was digested with KpnI followed by hybridization with the 5-probe to give the expected fragments for Slc38a1WT (20.2 kb) and
Slc38a1Null (15.7 kb). (D) Expression of Slc38a1 protein in brain lysates of Slc38a1+/+, Slc38a1+/−, and Slc38a1−/− mice was investigated. No protein expression is detected
in lysates from Slc38a1−/− mice, while Slc38a1+/- mice show reduced staining for Slc38a1 protein compared to Slc38a1+/+ mice. β-actin was used as loading control. E)
Expression of Slc38a1 protein was investigated by immunostaining of free-ﬂoating brain sections for Slc38a1. In the hippocampus, Slc38a1 immunoreactivity accumu-
lates in scattered interneuron-like cells in the CA1 and dentate area of Slc38a1+/+ mice. Such staining is abolished in sections from Slc38a1−/− mice. G, granulare; LM,
lacunosum-moleculare; M, moleculare; P, pyramidale; R, Radiatum. Insets: P, pyramidal cells; I, interneuron-like cell. Scale: 100 μm.
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external glutamine (Masson et al. 2006; Kam and Nicoll 2007).
Thus, conclusive experimental evidence for the function of Slc38a1
in vivo and its impact on inhibitory synaptic plasticity, and the
molecular determinants of GABA replenishment and GABAergic
vesicular load are lacking, and more broadly, for the existence of a
GGG cycle.
Here, we have genetically inactivated Slc38a1 in mice and
characterized their phenotype at successive levels of cellular
and network complexity in vitro and in vivo. We demonstrate
that Slc38a1 sustains replenishment of GABA, impacts vesicle
morphology and neurotransmitter content, triggers AP genera-
tion and regulates inhibitory synaptic plasticity in vivo.
Materials and Methods
Animal Handling
Experiments were approved and conducted in accordance with
the Norwegian Animal Welfare Act and the European
Convention for the Protection of Vertebrate Animals used for
Experimental and Other Scientiﬁc Purposes (ETS 123). The mice
were kept and handled under veterinary supervision at the
UiO. Mice were housed in a temperature controlled facility
(22–26 °C) with 50 ± 10% humidity and a 12-hours light/dark
cycle. Animals were served municipal water and fed ad libitum
with RM3 (E) from Special Diets Services (UK).
Discharge/frequency experiments on animals were per-
formed at Karolinska Institutet and conformed to the European
Communities Council Directive (86/609/EEC) and were approved
by the Stockholms Norra Djurförsöksetiska Nämnd (N26/2005
and N38/2005).
Generation of a ﬂoxed Slc38a1 Mouse
The ﬂoxed Slc38a1 targeting construct was produced (Fig. 1A)
using recombineering techniques (Liu et al. 2003). A 12 904 bp
genomic DNA fragment containing exons 5–12 of the Slc38a1
gene was retrieved from BAC clone RP23-85D13. A LoxP
sequence was inserted in intron 4 and a FRT-PGKNeo-FRT-LoxP
cassette was inserted in intron 8. Thus, a fragment of 4504 bp
genomic DNA containing exons 5 through 8 was ﬂoxed. Cre
excision would generate an out-of-frame deletion. The target-
ing vector was electroporated into D1 embryonic stem (ES) cells
which were derived from F1 hybrid blastocyst of 129S6 × C57BL/
6 J. G418 resistant ES colonies were isolated and screened by
nested polymerase chain reaction (PCR) using primers outside
the construct paired with primers inside the neo cassette.
Fourteen clones PCR positive for both arms were identiﬁed
from 48 clones screened. Chimeric mice were generated by
aggregating the ES cells with 8-cell embryos of CD-1 strain. The
neo cassette was removed by mating the chimeras with 129S4/
SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J (Stock number: 003946)
homozygous females. The F1 pups were genotyped by PCR
using primers ﬂanking LoxP or FRT-LoxP sites. The mice were
then crossed with Deleter mice to create a systemic deletion of
Slc38a1 (Schwenk et al. 1995). As Slc38a1 expression is
restricted to some few organs (Chaudhry et al. 2002), secondary
effects on the CNS phenotype is not very likely. Null mutant
(Slc38a1−/−) mice did not carry any obvious phenotypic abnor-
malities. We had several breedings (het x het, ko x ko, wt x wt)
and all were backcrossed between 5 and 10 times. In addition,
the mice were crossed with wt mice regularly in order to avoid
inbreeding of the mice in order to reduce the risk of differences
in the genetic background.
A new set of primers were designed for PCR genotyping. The
template DNA was obtained by digesting an ear piece using the
REDExtract-N-Amp™ Tissue PCR Kit (Sigma) followed by PCR-
ampliﬁcation of 1 μl of the template in a 10 μl PCR reaction. The
reaction was carried out for 35 cycles (94 °C 30 s, 60 °C 30 s and
72 °C 30 s) followed by one cycle of 72 °C for 10min.
Primers Used for Generation of a Floxed Slc38a1 Mice
and for Investigating Their Genotypes
The homologous arms were 2945 bp (5′) and 5440 bp (3′). Primer
sequences for ES screening were: 5′ arm forward primers: Slc38a1
Scr F1 (5′- cgtgttctccgtcagctatt-3′) and Slc38a1 Scr F2 (5′- atgtccgg-
cagagtctttga-3′). Reverse primers: LoxP Scr R1 (5′-gagggacctaa-
taacttcgt-3′) and LoxP Scr R2 (5′-ggaattgggctgcaggaatt-3′). 3′ arm
forward primers: FRT Scr F1 (5′-ttctgaggcggaaagaacca-3′) and FRT
Scr F2 (5′-cgaagttattaggtggatcc-3′); Reverse primers: Slc38a1 Scr R1
(5′-agtgatggtaaccgtcctgt-3′) and Slc38a1 Scr R2 (5′-ctactggccaggaa-
caacgat-3′).
A new set of primers were designed for PCR genotyping. The
primer combination Scl38a1-Scr1: (5′-tgtaggtctgttcccatgttgtcct-3′)
and Scl38a1-Scr2: (5′-gatgaaatgttccccggagtctaac-3′) generates a PCR
product of 426 bp for the wild type allele, and 514bp for the ﬂoxed
allele. The primer set Scl38a1-scr3 (5′-tctcccactaagttgcgttgtcttc-3′)
and Scl38a1-scr4(5′-ccaaatggatgacttggagattgtc-3′) generates a PCR
product of 372bp for the wild type allele and 471bp for the ﬂoxed
allele. Detection of the null allele after Cre excision was detected
using the primer combination Scl38a1-Scr1 and Scl38a1-Scr4 giving
a PCR product of 616 bp for the null allele and a fragment too large
to be ampliﬁed for the wild type allele.
Southern Blotting
The probe sequence was radiolabelled with [a-32P]dCTP (Perkin
Elmer, Wellesley, MA) using Megaprime DNA labelling System
(Amersham Biosciences) prior to hybridization of the mem-
brane to verify homologous recombination of the loci in the
animals.
Synaptosomes, Amino Acid Analysis, and Quantitative
Western Blotting
Synaptosomes were made by homogenization of the brains in ice
cold 0.32M sucrose 5% (w/v) followed by several steps of ultracen-
trifugation, as described (Bogen et al. 2006). Synaptosomal amino
acids were separated and quantiﬁed by HPLC and ﬂuorescence
detection after pre-column derivatization with o-phthaldialdehyde
(Hassel and Brathe 2000). Western blot analyses were performed
as described (Nissen-Meyer et al. 2011). For details, see SI.
Light- and Electron Microscopic Cytochemistry
Ten pairs of age- and sex-matched Slc38a1+/+ and Slc38a1−/−
mice were deeply anesthetized with intra-peritoneal injection
of Zoletil-mix 125mg/kg. Five of the pairs were ﬁxed by trans-
cardiac perfusion of 4% paraformaldehyde (PFA) for immune-
peroxidase staining and 5 pairs were perfusion ﬁxed with 4%
PFA and 2.5% glutaraldehyde (GA), hippocampal CA1 regions
dissected out, embedded in Durcupan (FLUKA), sectioned
(~100 nm), immunogold labeled and analyzed by Electron
microscopy, as described (SI; Jenstad et al. 2009; Solbu et al.
2010).
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Antibodies
Antibodies were generated against the most divergent and
antigenic regions of the members of the Slc38 family of amino
acid/glutamine transporters, Slc17 family of vesicular gluta-
mate transporters and Slc32 family of vesicular GABA trans-
porter by subcloning these sequences C-terminal to the
sequence for glutathione-S-transferase (GST), inducing the pro-
tein in Escherichia coli and immunizing 2–6 rabbits for each
protein. The antiserum obtained has been vigorously afﬁnity
puriﬁed by absorbing against immobilized GST followed by iso-
lating on a column with immobilized GST-fusion protein con-
taining the antigenic peptide used to immunize rabbits. These
antibodies have then been properly characterized in our previ-
ous publications (e.g., Chaudhry et al. 1998; Boulland et al. 2003;
Boulland et al. 2004; Jenstad et al. 2009; Solbu et al. 2010;
Hamdani et al. 2012). Antibodies against AAs were generated by
conjugating Bovine Serum Albumin (BSA) to the AAs by glutar-
aldehyde. The BSA-conjugates were separated by dialysis and
mixed with adjuvant and injected intracutaneously in rabbits.
Please, see detailed information on the procedure (Ottersen
and Storm-Mathisen 1984) and the characterization of some of
the antibodies in our previous publications (Jenstad et al. 2009;
Solbu et al. 2010). Commercial antibodies against other proteins
were used according to recommendations from the companies.
Goat anti-rabbit and anti-mouse IgG Horseradish Peroxidase for
western blotting (Thermo Fischer Scientiﬁc) and the biotin-
streptavidin-peroxidase system and DAB were used as
described earlier (Jenstad et al. 2009; Solbu et al. 2010).
Commercial antibodies against other proteins were only used if
they showed right band on western blots and had been charac-
terized and published elsewhere. They were used according to
recommendations from the companies.
Extracellular Recordings
Extracellular recordings were performed on 400 μm thick hippo-
campal slices prepared from adult (>P60) from Slc38a1+/+ and
Slc38a1−/− mice. Data are presented as mean ± S.E.M. Statistical
signiﬁcance was evaluated by using a linear mixed model anal-
ysis (SAS 9.1), with P < 0.05 being designated as statistically sig-
niﬁcant. See SI for details.
Interneuron studies
Isolation of interneurons and their analyses were performed
according to (Berghuis et al. 2004). For details, see SI.
Monocular Deprivation and In vivo Electrophysiology
Extracellular recordings of single unit activity and local ﬁeld
potentials were made using linear silicone probes with 16
recording sites spaced at 50 μm intervals (NeuroNexus probes,
A1x16-3mm-50-177). Craniotomies to expose the primary
visual cortex (2mm in diameter, 1mm anterior and 3mm lat-
eral to lambda) were made above one (contralateral to the
deprived eye in MD animals or both hemispheres (control ani-
mals). The electrode was lowered into the brain to a depth of
1000 μm in the V1B, and was allowed to settle for 20min before
recording. Electrophysiological recordings were performed
under light isoﬂurane anesthesia (0.5–1%) supplemented with
intramuscular administration of chlorprothixene (0.2mg).
Visual stimuli was generated using Psychophysics Toolbox
extension (Brainard et al. 1997) for MATLAB (Mathworks) and
sinusiodal drifting gratings were displayed on a 21” computer
monitor centered 25 cm in front of the animal. Four days of MD
was started between postnatal day 25 (P25) and P27. Eyelids
were sutured shut under isoﬂurane anesthesia.
Statistical Analysis
All values are presented as mean ± SEM. All data were analyzed
by linear mixed models followed by comparisons of least
square means. Statistical tests were performed in R.
Results
Genetic Inactivation of Slc38a1 Abolishes Interneuron-
Like Localization
In order to examine the potential involvement of Slc38a1 in
GABA replenishment and synaptic plasticity in vivo, we used
the binary Cre/LoxP system to genetically inactivate Slc38a1 in
mice by deleting exons 5–8 (Fig. 1A). Genetic identity was con-
ﬁrmed by PCR using 3 pairs of primers and by Southern blotting
(Fig. 1B–C). The genotypes were further corroborated by analy-
ses of RNA transcripts (not shown) and Slc38a1 protein expres-
sion by Western blotting showing no expression of the protein
in Slc38a1−/− mice (Fig. 1D). In brain, overall cell numbers and
cortical cytoarchitecture were identical in both genotypes
(Fig. S1A–F). Immunoperoxidase staining for Slc38a1 accumu-
lates in scattered interneuron-like cells in Slc38a1+/+ mice
while it is entirely abolished in brain sections from Slc38a1−/−
mice (Fig. 1E, S1G–J). Thus, DNA, RNA and protein analyses con-
ﬁrm successful inactivation of Slc38a1 in mice, and exclude
major phenotypic abnormalities for brain anatomy. Moreover,
these data points to Slc38a1 as speciﬁc for neurons with
interneuron-like layer distribution.
Slc38a1 Inactivation Alters Levels of Key AAs and
Enzymes Involved in GABA Synthesis
We next investigated the functional signiﬁcance of Slc38a1-
mediated glutamine transport for the metabolic and/or neuro-
transmitter pools of several AAs. Analyses of forebrain extracts
obtained from Slc38a1+/+ and Slc38a1−/− mice show signiﬁ-
cantly reduced levels of AAs associated with the GABA meta-
bolism and the GGG cycle, i.e., glutamine, glutamate, GABA and
aspartate (Fig. 2A). In contrast, other AAs, such as alanine, ser-
ine, glycine, and taurine, remained unchanged upon Slc38a1
inactivation (Fig. 2A). These data implicate a role for Slc38a1 in
the replenishment of AAs potentially involved in GABAergic
neurotransmission in vivo.
Next, we assessed whether the reduced pools of AAs repre-
sented metabolic intermediates or neurotransmitters by analyz-
ing synaptosomal fractions from Slc38a1+/+ and Slc38a1−/− mice
for AA content. Synaptosomes are suitable for ﬁrst assessment of
specialized neurotransmitter pools (Biesemann et al. 2014; Hassel
et al. 2015) although they are contaminated with gliosomes. We
detected a signiﬁcant reduction in synaptosomal glutamine and
aspartate levels (Fig. 2B), the latter is formed downstream of
GABA. In contrast, the GABA-homolog taurine—an osmolyte that
does not participate in GABA metabolism or the GGG cycle—
remains unchanged upon Slc38a1 inactivation (Fig. 2B).
As synaptosomal GABA levels are sub-signiﬁcantly reduced,
we hypothesized that Slc38a1 disruption activates compensa-
tory mechanisms to maintain GABAergic neurotransmission.
We therefore quantiﬁed key proteins involved in glutamate and
GABA metabolism and signaling. Relative to wild-type (wt) lit-
termates, Slc38a1−/− mice showed signiﬁcantly higher levels of
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GAD67, the enzyme catalyzing glutamate to GABA conversion
(Fig. 2C). Likewise, the upstream enzyme, PAG, catalyzing gluta-
mine to glutamate conversion, is up-regulated in Slc38a1−/−
mice (Fig. 2C). This suggests that GABA formation is distorted
and that 2 key enzymes in the GABA synthesis pathway are up-
regulated to overcome metabolic restrictions to maintain GABA
(and its precursor glutamate) in nerve terminals. Expression of
proteins contributing to the vesicular sequestration of GABA or
glutamate, their receptors or plasma membrane transporters,
remained unchanged. Altogether, our data suggest a selective
role for Slc38a1 in GABA replenishment in harmony with its
localization in interneurons (Fig. 1E, S1G–J).
Slc38a1 Deletion Alters Vesicle Morphology and
Reduces Vesicular GABA Content
In order to reveal the impact of Slc38a1 on vesicular neuro-
transmitter content and synaptic transmission, we next stud-
ied synapse morphology and concentrations of the 2 main fast
neurotransmitters and their putative precursor by electron
microscopy. In the hippocampus, the number and morphologi-
cal appearance of synapses, as well as subcellular structures
were unchanged between Slc38a1+/+ and Slc38a1−/− mice
(Fig. 3A and B, S2A). Immunogold labeling of inhibitory nerve
terminals (which represents the total vesicular and extra-
vesicular concentration of the amino acids) of the hippocampal
CA1 demonstrated signiﬁcant reduction of glutamine and glu-
tamate while GABA levels were sustained (Fig. 3A–C). This is
congruous with a shift in the equilibrium to form GABA at the
expense of its 2 precursors, glutamine and glutamate, and is
consistent with our synaptosomal HPLC data and upregulated
PAG and GAD67 expressions (Fig. 2). The selective role of
Slc38a1 in GABAergic neurotransmitter replenishment is cor-
roborated by a lack of any inﬂuence in adjacent glutamatergic
nerve terminals since both glutamine and glutamate concen-
trations are preserved in Slc38a1−/− mice (Fig. 3D).
We then speciﬁcally focused on synaptic vesicles: the relative
distribution of synaptic vesicles from the release site remains
intact in Slc38a1−/− mice (Fig. S2B). However, the density of syn-
aptic vesicles in Slc38a1−/− GABAergic terminals is increased
(Fig. 3E; ~21% augmentment). In addition, there is a small, but
signiﬁcant reduction (in the circumference of GABAergic synap-
tic vesicles (Fig. 3F; ~8% reduction in volume). This is corrobo-
rated by immunogold labeling for GABA showing reduced
vesicular content (Fig. 3G; ~16% GABA reduction). However,
Slc38a1 inactivation was not associated with any signiﬁcant
change in the length of the post-synaptic density at GABAergic
synapses (Fig. 3H) suggesting that Slc38a1−/− synapses retain
GABA signaling at near-physiological levels. Interestingly,
Slc38a1 deletion has no impact on vesicle density, vesicle cir-
cumference or vesicular neurotransmitter content in glutama-
tergic nerve terminals (Fig. 3E–G) corroborating a selective
impact on GABAergic neurotransmission. Thus, Slc38a1 disrup-
tion signiﬁcantly reduces the speciﬁc vesicular GABA content.
Slc38a1−/−Mice Retain Normal Excitatory Synaptic
Transmission and Synaptic Plasticity
To investigate any functional role for Slc38a1 in excitatory syn-
aptic transmission and synaptic excitability, simultaneous
electrophysiological recordings were conducted in the apical
dendritic and soma layers in the CA1 region of hippocampal
slices from Slc38a1−/− and Slc38a1+/+ mice. We found no sub-
stantial differences in ﬁber density, number of afferent ﬁbers,
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Figure 2. Slc38a1 inactivation reduces selectively levels of amino acids (AA) and
increases levels of proteins sustaining GABA transmission. (A) The concentration
of AAs in forebrains of Slc38a1−/− (red) and Slc38a1+/+ (black) mice (n = 5 in each
group) were investigated by HPLC. Signiﬁcant reduction in the levels of glutamine
(Gln), glutamate (Glu), GABA and aspartate (Asp) was detected upon Slc38a1 inacti-
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(Gly) or taurine (Tau), were not altered. (B) Synaptosomes were made from brains
of Slc38a1−/− (red) and Slc38a1+/+ (black) mice and their content of AAs was mea-
sured by HPLC: Glutamine and aspartate are signiﬁcantly reduced. Glutamate and
GABA are sub-signiﬁcantly reduced, while there is no difference in the concentra-
tions of taurine in Slc38a1−/− compared to Slc38a1+/+. (C) Quantitative immunoblot-
ting of total brain extracts from Slc38a1−/− and Slc38a1+/+ mice shows signiﬁcant
up-regulation of GAD67 and PAG in Slc38a1−/− mice compared to Slc38a1+/+ mice.
Proteins associated with glutamatergic neurotransmission, such as NR2B and
VGLUT1, are not increased. GAD67, Glutamic acid decarboxylate (GAD) 67 kDa;
PAG, (kidney) Phosphate-activated glutaminase; Slc38a2, Slc38 family member 2:
The System A transporter 2 (SAT2/SNAT2); GS, Glutamine synthetase; GABA-T,
GABA aminotransferase; GAD65, GAD 65 kDa; Rab3a, The RAS-related protein
3A; GABAAR, GABAA receptor; EAAT3, Excitatory amino acid transporter (EAAT) 3
(Slc1a1); EAAT1 (Slc1a3); SNAP25, Synaptosomal-associated protein 25; GAT1,
GABA transporter 1 (Slc6a1); EAAT2 (Slc1a2); Slc38a3, Slc38 family member 3: The
System N transporter 1 (SN1/SNAT3); VGLUT2, Vesicular glutamate transporter
(VGLUT) 2 (Slc17a6); VGAT, Vesicular GABA transporter (Slc32); VAMP, Vesicle-
associated membrane protein; NR2B, NR2B subunit of NMDA receptor; VGLUT1
(Slc17a7). Red and black bars in A and B: Slx38a1−/− and Slx38a1+/+, respectively.
Data are mean ± SD values. Asterisk: different from control; P < 0.007 (A,C:
unpaired Student’s t-test, B: Mann–Whitney test).
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amount of excitatory synaptic transmission or excitability
(Fig. 4A–C). Thus, these results do not support any major
changes in either excitatory synaptic transmission or in post-
synaptic excitability when tested by synaptic activation, and
reconcile well with our electron microscopy data on glutama-
tergic synapses. A comparison of paired-pulse facilitation, a
short-lasting form of synaptic plasticity primarily attributed to
changes in presynaptic Ca2+ homeostasis (Zucker and Regehr
2002), reveals no signiﬁcant difference between the 2 genotypes
(Fig. 4D). Finally, prolonged activation (20 Hz 50 s) of afferent
ﬁbers in the CA3-to-CA1 pathway or examination of LTP at hip-
pocampal CA3-to-CA1 synapses in slices taken from adult mice
showed no differences between the 2 genotypes (Fig. 4E–G).
Altogether, our data do not show any major impact of Slc38a1
inactivation on glutamatergic synaptic transmission (See SI for
detailed results).
Glutamine Discharges Perisomatic Interneurons
As Slc38a1 is preferentially expressed by hippocampal and cor-
tical parvalbumin (PV)+ interneurons (also termed fast-spiking
(FS) cells; Fig. 5A), we hypothesized that particularly efﬁcacious
means of GABA replenishment might have evolved to drive AP
ﬁring at high frequencies. Here, we pharmacologically probe
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Figure 3. Slc38a1 inactivation alters synaptic vesicle morphology and GABAergic vesicular load. Pieces of hippocampal CA1 from Slc38a1+/+ and Slc38a1−/− mice were
dissected out, embedded in resins and examined by immunogold electron microscopy. (A–B) Two electron micrographs (from Slc38a1+/+ and Slc38a1−/− mice, respec-
tively) showing putative GABAergic nerve terminals making symmetric synapses onto pyramidal cell dendrites and stained for glutamine. Arrow heads demark syn-
apses. (C) In GABAergic nerve terminals of the stratum radiatum, the immunoreactivities for glutamine and glutamate are signiﬁcantly reduced while GABA levels
are sustained in Slc38a1−/− mice compared to Slc38a1+/+ mice. (D) Immunoreactivities for glutamine or glutamate in neighboring glutamatergic nerve terminals are
not reduced upon deletion of Slc38a1. (E) The density of synaptic vesicles in putative GABAergic nerve terminals is increased in Slc38a1−/− mice compared to
Slc38a1+/+ mice. Such change in synaptic vesicle density is not seen in adjacent glutamatergic nerve terminals. (F) The circumference of synaptic vesicles in
GABAergic and glutamatergic nerve terminals was measured. GABA+ synaptic vesicles had a small but signiﬁcant reduction in the circumference in Slc38a1−/− mice.
The circumference of synaptic vesicles in glutamatergic nerve terminals withstood any changes upon genetic inactivation of Slc38a1. (G) The vesicular concentration
of GABA and glutamate was assessed by measuring immunogold labeling of synaptic vesicles. Vesicular GABA is reduced in Slc38a1 knock-out mice compared to the
wild type mice. No signiﬁcant changes were detected for the vesicular glutamate concentration. (H) There is no signiﬁcant change in the size of the postsynaptic den-
sity (PSD) at GABAergic synapses in Slc38a1−/− mice compared to Slc38a1+/+ mice. Structures or staining related to GABAergic or glutamatergic synapses are shown in
red and blue, respectively, while the black bars represent the corresponding structures or staining in wt mice. The numbers written on the bars indicate the number
of structures analyzed. In E-H the percentage ratio between data obtained in Slc38a1−/− and Slc38a1+/+ are shown. m, miotchondria; T, terminal. Asterisk: different
from control; P < 0.007, unpaired Student’s t-test.
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Figure 4. Normal hippocampal excitatory transmission and synaptic plasticity prevail in Slc38a1−/− mice. Excitatory transmission and short- and long-term synaptic plastic-
ity were investigated at hippocampal CA3-to-CA1 synapses. (A) There are no changes in stimulation strengths necessary to elicit a ﬁber volley of given amplitudes (0.5, 1.0
and 1.5mV) in Slc38a1−/− mice compared to wild type mice suggesting no difference in ﬁber density/number of afferents. (B) Field excitatory post-synaptic potential (fEPSP)
amplitudes as a function of the same 3 ﬁber volley amplitudes are equal in the 2 genotypes suggesting normal excitatory synaptic transmission. (C) The fEPSP amplitudes
necessary to elicit a just detectable population spike (1) and a population spike of 2mV (2) are not altered suggesting no impact on pyramidal cell excitability. (D) No signiﬁ-
cant changes were detected in the paired-pulse facilitation (PPF) ratio in the 2 genotypes at an interstimulus interval of 50ms. (E) Top row; each trace is the mean of 5 conse-
cutive synaptic responses in stratum radiatum elicited by different stimulation strengths in slices from Slc38a1+/+ (left) and Slc38a1−/− (right) mice. The prevolleys preceding
the fEPSPs are indicated by circles. Bottom row; recordings from stratum pyramidale elicited by paired-pulse stimulation (50ms interstimulus interval). Arrowheads indicate
the population spike thresholds. (F) Normalized and pooled fEPSP slope measurements during the initial 30 seconds of 20Hz stimulation in stratum radiatum in slices from
Slc38a1+/+ and Slc38a1−/−mice. Vertical bars indicate S.E.M. Subtractions of the values obtained in Slc38a1+/+ mice from those obtained in Slc38a1−/−mice are represented by
the black, open symbols. The inset graph shows a the time point of the maximum magnitude of the initial frequency facilitation (as indicated by an arrow in the ﬁgure), b
time point to the transition point between the initial frequency facilitation and the delayed response enhancement (DRE), c time needed to reach the peak of the DRE. (G)
Normalized, pooled and superimposed extracellular fEPSP slopes evoked at CA3–to-CA1 synapses in slices from Slc38a1+/+ and Slc38a1−/− mice. Tetanized pathways are
shown with circles and untetanized control pathways are shown with squares. Arrowhead indicates time point of tetanic stimulation. D, F and G suggest no major differ-
ences between the genotypes in some forms of short-term and long-term synaptic plasticity. Data are shown as mean ± standard error of mean (S.E.M). Experiments are
shown with open symbols for Slc38a1+/+ mice and red, ﬁlled symbols for Slc38a1−/−. None of the comparisons between the genotypes were statistically signiﬁcant (P < 0.05).
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Slc38a1-dependent glutamine uptake for GABA production and
vesicular ﬁlling and correlate this with neuronal AP patterns.
Besides ex vivo slice recordings, we developed a culture protocol
to speciﬁcally enrich and maintain FS cells (Berghuis et al.
2004). We also used irregular-spiking (IR-like) interneurons
with discharge frequencies <50 Hz as controls.
Glutamine uptake through SATs was previously reported to
depolarize interneurons and to induce paired-pulse facilitation
at inhibitory synapses in the hippocampus (Chaudhry et al.
2002). Here, we ﬁrst reproduced these ﬁndings by applying
5mM glutamine (for lower concentrations, data not shown) that
depolarized PV+ cortical interneurons (Fig. 5A–B). Glutamine
transport through SATs relies on Na+ co-transport with maxi-
mal transporter efﬁcacy at resting membrane potentials in the
presence of high Na+ concentrations (Chaudhry et al. 2002).
Indeed, membrane depolarization was driven by an inward Na+
current with its reversal potential closely matching the calcu-
lated Na+ reversal potential (0mV) when using 20mM KCl
intracellularly (Fig. 5C). Moreover, glutamine transport in FS
cells showed signiﬁcant outward rectiﬁcation at <−50mV as
opposed to a linear I-V relationship seen in control (Fig. 5C; S3B)
and upon washout (data not shown) in the presence of 125mM
extracellular Na+ and pharmacologically-muted synaptic neu-
rotransmission. Input resistance did not change during
glutamine-induced depolarization, suggesting gating by intra-
membrane proteins without “on-demand” membrane insertion,
and reversed upon wash-out (Fig. S3A). These data suggest that
glutamine undergoes Na+-dependent electrogenic transport in
FS cells through a mechanism operating well at deep resting
membrane potentials, which corroborates data on transporter
kinetics when Slc38a1 was expressed heterologously in
Xenopus oocytes (Chaudhry et al. 2002).
Previously, glutamine-induced depolarization was esti-
mated as ≤ 5mV (Chaudhry et al. 2002) when measured at low
temporal resolution. We reproduced these records at high sam-
pling rates and using methyl aminoisobutyric acid (MeAIB) as
SAT substrate to show an incremental (±3mV) depolarization
(Fig. 5D). However, when co-applying glutamine, we found a
rapid membrane shift towards −40mV (AP threshold for cul-
tured FS cells (Berghuis et al. 2004), above which repetitive
membrane oscillations with frequencies ranging from 1.8 to
2.5 Hz occurred (Fig. 5D). Glutamine-induced oscillations over-
shot 0mV, thus qualifying as AP trains, and were long-lasting
yet tended to decrease in frequency (Fig. 5D, end of trace). We
attributed their gradual decline to metabolic strain on the neu-
rons we probed. Moreover, both MeAIB and glutamine
markedly increased the amplitude of spontaneous inhibitory
postsynaptic currents (sIPSCs; 145.9 ± 9.8% and 180.3 ± 13.2% of
the baseline, respectively; Fig. S3C) when measured in FS cells
receiving signiﬁcant recurrent inhibitory input from other FS
cells in hippocampal CA1 (Galarreta and Hestrin 1999). Thus,
glutamine uptake through Slc38a1 might reset network excit-
ability by driving FS cell activity.
We then exploited interneuron-enriched cultures (Berghuis
et al. 2004) to dissect the electrogenic signature of glutamine
uptake. In FS-like cells, which expressed Slc38a1 perisomatically
as well as in processes (Fig. 5E, E1), current-clamp recordings
showed that increasing the glutamine concentration from 2 to
5mM extracellularly evoked robust depolarization (P < 0.05 at 3
and 6min vs. IR controls, n = 7/12; Fig. 5F). Discharge events
were highly ordered, their frequency increased with ongoing glu-
tamine superfusion (Fig. 5G), and reached steady-state by ~5min
of glutamine application when the raid surge in membrane
potential is followed by a 1–2 s depolarization state and a
subsequent rapid repolarization step (Fig. 5G1, panel c). Upon glu-
tamine wash-out, both the frequency and amplitude of mem-
brane depolarization gradually subsided. Pre-treatment with
100 μM 3-Mercaptopropionic acid (3-MPA), a GAD inhibitor, abol-
ished glutamine-induced depolarization, suggesting end-point
(product) regulation (Fig. 5F). These events were insensitive to
AMPA, kainate or mGluR antagonists, excluding bias by
glutamine-to-glutamate conversion (Fig. S3D, D1). Moreover, glu-
tamine primes this phenomenon since step-wise depolarization
fails to evoke any similar discharge (Fig. S3E). Notably,
glutamine-induced changes were observed in FS-like but less so
in IR-like cells (Fig. 5F), which is consistent with IR-like cells
expressing alternative transport systems. Collectively, we sug-
gest that glutamine can tonically excite FS interneurons, at least
in isolation.
Deletion of Slc38a1 Alters Gamma Oscillations In vivo
Given that pharmacological probing of Slc38a1 alters interneu-
ron activity and that maturation of PV+ FS neurons dictates
onset of the enhanced plasticity period in early postnatal life
(Hensch 2005), we next investigated if cortical processing and
plasticity were also altered in the Slc38a1−/− in vivo.
Extracellular recordings of single unit activity and local ﬁeld
potentials (LFP) from the primary visual cortex of anesthetised
Slc38a1−/− mice at the peak of the critical period (P29-31)
revealed that oscillations in the gamma (ɣ) frequency band
(30–90 Hz) were signiﬁcantly slower compared to Slc38a1+/+
(Fig. 6A–B). Gamma activity is thought to be important for cog-
nition and arises from synchronous activity of FS PV+ inter-
neurons (Buzsaki and Wang 2012). The slower ɣ frequency of
the Slc38a1−/− resembles what has been found in immature PV+
network where there is also lower levels of GABA and which is
characteristic of pre- critical period conditions (Hensch 2005;
Ben-Ari et al. 2007).
Deletion of Slc38a1 Alters the Activity of Visual Cortex
Inhibitory Neurons
To examine if Slc38a1 deletion affects neuronal activity on the
single-cell level we recorded 282 single units from the primary
visual cortex (109 units from Slc38a1−/− (N = 11) and 173 from
Slc38a1+/+ (N = 11)). Recorded units were classiﬁed as putatively
excitatory (broad-spiking) or inhibitory (narrow-spiking) neu-
rons based on spike waveform parameters (Bartho et al. 2004)
(Fig. 6C–D, S4A).
Both genotypes responded to visual stimuli (drifting grat-
ings) (Fig. 6E), and ﬁring rates of excitatory units were compara-
ble between Slc38a1−/− and Slc38a1+/+ (Slc38a1−/−: 1.7 ± 04
spikes/s versus Slc38a1+/+: 2.1 ± 0.4 spikes/s; Fig. 6F). In con-
trast, spontaneous activity of inhibitory units recorded in
Slc38a1−/− mice was signiﬁcantly higher than that of Slc38a1+/+
(Slc38a1−/−: 3.1 ± 0.9 spikes/s versus Slc38a1+/+: 1.5 ± 0.4 spikes/
s, generalized linear model, pgenotype:unit type = 0.04, com-
parisons of least square means, inhibitory units: Slc38a1−/− vs.
Slc38a1+/+: P = 0.009); Fig. 6F), while stimulus-evoked rates did
not differ (Fig. S5D). The selective effect of Slc38a1 deletion on
baseline activity of inhibitory neurons is consistent with
impaired GABAergic neurotransmission and perturbed dis-
charges in FS PV+ interneurons.
Visual cortex neurons respond with preference to stimuli
consisting of high contrast lines of speciﬁc orientations.
Response strength to the preferred orientation measured as ori-
entation selectivity index (OSI) was not affected by Slc38a1
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deletion in neither excitatory nor inhibitory units (Fig. S4B–C),
suggesting that the Slc38a1 deletion does not inﬂuence basic
responses to sensory stimulation.
Slc38a1 Deletion Impairs Ocular Dominance Plasticity
Altered inhibitory neuron activity of Slc38a1−/− resembles that
of an immature neural network and could contribute to
impaired cortical plasticity. To test this, we used the classical
model of ocular dominance plasticity in the primary visual cor-
tex (Levelt and Hubener 2012). The majority of neurons in the
binocular part of the primary visual cortex respond stronger to
stimulation of the contralateral eye than the ipsilateral eye, a
phenomenon called ocular dominance. If the dominant eye is
deprived of adequate sensory input during the critical period,
the population of binocular neurons will shift their preference
towards the non-deprived eye (Hubel et al. 1977). As deletion of
Slc38a1 impairs GABAergic function, we posited that ocular
dominance plasticity during the critical period is affected in
Slc38a1−/− mice. Activity-dependent plasticity was experimen-
tally induced by MD for 4 days during the critical period. MD
caused a shift in eye preference for excitatory units from the
contralateral (deprived) towards the ipsilateral (non-deprived) eye,
measured as a reduction in contralateral bias, but the shift was
only signiﬁcant for Slc38a1+/+ animals (Fig. 7A–C). Conversely,
inhibitory neurons from Slc38a1+/+ displayed a shift towards pref-
erence for the contralateral (deprived) eye after MD, something
which was not seen in Slc38a1−/− animals (Fig. 7D–F).
MD signiﬁcantly reduced the spontaneous ﬁring rates of
both Slc38a1−/− and Slc38a1+/+ inhibitory neurons (Fig. S5).
Despite their reduced activity, Slc38a1−/− inhibitory units still
showed higher spontaneous activity than Slc38a1+/+ after MD
(S5C). Absence of a normal MD response in Slc38a1−/− animals
and the apparent reduction in stimulus-evoked rate of excit-
atory units after MD (Fig. S5B), resemble pre-critical period con-
ditions (Smith and Trachtenberg 2007). This suggests that
Figure 5. Glutamine induces high-frequency membrane oscillations in neocortical and hippocampal fast-spiking (FS) cells. (A) FS cells in CA1 stratum radiatum express
the system A transporter Slc38a1. (B) Glutamine induces membrane depolarization of FS interneurons (upper panel) and generates an inward current (bottom panel;
clamped at −70mV), which are reversed upon wash-out. Red and blue dashed lines indicate resting membrane potentials at the start and end of current clamp record-
ings, respectively. (C) Current – voltage relationship of SAT-mediated currents. Open squares refer to superfusion in control, while ﬁlled circles in the presence of gluta-
mine (6min). Note the glutamine-induced outward rectiﬁcation. *p < 0.05 vs. control (Student’s t-test, n = 6). The reversal potential, conferring to the cross at the
abscissa, did not change. (D) Representative current clamp record shows membrane potential oscillations induced by MeAIB and glutamine. Note that glutamine but not
MeAIB alone depolarizes the recorded cell. E) Cultured FS-like cells were Slc38a1 immunoreactive at 12 days in vitro. Note Slc38a1 localization to varicose axon segments
(E1). Scale bars = 30 μm (E), 4 μm (E1). (F) Glutamine-induced membrane potential depolarization is rapid in FS-like but less so in IR-like interneurons. 3-Mercaptopropionic
acid (3-MPA) occludes this response. *P < 0.05 vs. baseline at 0min (Student’s t-test). gray area denotes the 6-min period of glutamine superfusion. 3-MPA was applied for
16h at 100 μM concentration. Data were expressed as means from n = 12–15 cells/condition. (G) Glutamine elicited a progressive increase in the frequency of membrane
oscillations, which can transiently exceed 0mV after glutamine application for 6min with gradual repolarization upon wash-out. Vertical gray bars indicate the posi-
tions of high-resolution panels (a-d) in G1. Note the highly conserved time constant and amplitude of unitary Slc38a1-mediated conductance changes.
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deletion of Slc38a1 may contribute to render the cortical net-
work in an immature state; unable to enter the critical period
due to impaired GABA signaling. In this respect, Slc38a1
appears to be of fundamental importance for normal cortical
development and GABA-dependent plasticity.
Discussion
We establish that Slc38a1 is enriched in PV+ interneurons and that
Slc38a1 disruption has impact on synaptic vesicle size, vesicular
load and GABAergic signaling (for summary of the results see
Fig. S6). Slc38a1 drives FS cell activity, triggers AP generation and
regulates network excitability. Genetic inactivation of Slc38a1
altered ocular dominance plasticity and γ oscillations suggesting
impaired GABA signaling resembling neuronal networks in an
immature state. Collectively, our data implicate that Slc38a1 contri-
butes to normal cortical development and plasticity. Thus, dys-
functional glutamine supply and Slc38a1 activity may contribute to
neurologic dysfunction such as in epilepsy, autism, schizophrenia
and anxiety (Soghomonian and Martin 1998; Lewis et al. 2012).
Slc38a1 Aids Interneurons to Replenish
Neurotransmitter Pools of GABA
Slc38a1−/− mice helped us to show that Slc38a1 is intrinsic to
glutamine transport into GABAergic neurons to sustain GABA
neurotransmitter pools: glutamine and aspartate, upstream
and downstream metabolites of GABA, respectively, are selec-
tively and signiﬁcantly reduced in forebrain extracts and syn-
aptosomal fractions. The signiﬁcant reduction in aspartate in
brain extracts and synaptosomes is indicative of a reduced
inﬂux of glutamine into the tricarboxylic acid (TCA) cycle of
GABAergic neurons, leading to a reduced formation of TCA
cycle end product, which equilibrates with aspartate. Our data
agree with the notion that system A activity being responsible
for 87% of neuronal uptake of glutamine (Kanamori and Ross
2006). Furthermore, they corroborate glutamine as a major pre-
cursor for transmitter GABA synthesis, consistent with a large
number of classical studies (e.g., Paulsen et al. 1988; Sonnewald
et al. 2006). Indeed, oral glutamine supplementation increases
CNS levels of GABA (Wang et al. 2007).
A B C
D E F
Figure 6. Slc38a1 inactivation alters population activity in vivo. (A) Examples of power spectra of LFP in Slc38a1−/− (red) compared to Slc38a1+/+ control (black). The
peak in the power spectrum of the local ﬁeld potential was identiﬁed in the gamma range (30–90 Hz). (B) Gamma peak frequency was signiﬁcantly lower in slc38a1−/−
mice (n = 10) compared to controls (n = 11) (Slc38a1−/−: 37 ± 1Hz, wt: 44 ± 1Hz,. Linear mixed model, *pgenotype = 0.03). (C) Example waveforms of a broad-spiking puta-
tive excitatory unit (green) and narrow-spiking putative inhibitory unit (blue) (D) Spike waveform width plotted against peak-to-trough time for all units (n = 273)
showing separate clustering of inhibitory units and excitatory units (ﬁlled circles: excitatory units; open circles: inhibitory units). Units were classiﬁed based on princi-
pal component analysis of waveform parameters. (E) Peristimulus histogram showing average ﬁring rate of putative excitatory neurons in response to visual stimuli
of both eyes. Stimulus onset at time 0 (gray line). (F) No difference in spontaneous ﬁring rates of excitatory neurons between the genotypes (Slc38a1−/−: 1.7 ± 0.4
spikes/s versus Slc38a1+/+: 2.1 ± 0.4 spikes/s). The spontaneous activity of inhibitory units recorded from Slc38a1−/− mice is signiﬁcantly higher than that of Slc38a1+/+
(Slc38a1−/−: 3.1 ± 0.9 spikes/s versus Slc38a1+/+: 1.5 ± 0.4 spikes/s, generalized linear model, pgenotype:unit type = 0.04, comparisons of least square means, inhibitory
units: Slc38a1−/− vs. Slc38a1+/+: P = 0.009).
Slc38a1 in GABAergic Transmission and Plasticity Qureshi et al. | 5175
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/article-abstract/29/12/5166/5485254 by R
oyal Library C
openhagen U
niversity user on 27 January 2020
As the reduction of glutamine and GABA in Slc38a1−/− mice
is signiﬁcant yet they survive and process information properly,
we suggest the existence of alternative pathways to maintain a
certain level of vesicular GABA. In Slc38a1−/− mice, GAT1
expression is preserved. This suggests that GABA re-uptake
into nerve terminals maintains basic GABAergic activity and
prevents mal-development and/or mal-function of the brain as
described for GAT1−/− mice (Jensen et al. 2003). Key enzymes
involved in GABA synthesis from glutamine (GAD67 and PAG)
are signiﬁcantly increased, and the preservation of GABA
occurs at the expense of glutamine and glutamate. Tonic non-
vesicular release of GABA from GABAergic neurons or astroglial
cells, e.g., by the calcium-activated anion channel Bestrophin-1
(Lee and Schwab 2011; Oh and Lee 2017; Soghomonian and
Martin 1998) may also contribute to maintain GABAergic activ-
ity. Thus, Slc38a1 is intrinsic for GABA formation, with addi-
tional mechanisms existing to partly offset the metabolic drain
that occurs in Slc38a1 ko animals.
Interestingly, Slc38a1 inactivation upregulates GAD67 but not
GAD65. GAD65 is enriched in nerve terminals, functionally
couples to VGAT on synaptic vesicle membranes to facilitate the
generation and accumulation of GABA inside synaptic vesicles
for phasic synaptic release (Jin et al. 2003). In contrast, GAD67 is
shown to synthesize most GABA and is involved in generating
GABA also for non-vesicular release and tonic ﬁring (Buddhala
et al. 2009). Interestingly, GAD67−/− mice have signiﬁcantly
reduced brain GABA concentrations while GABA levels appear
normal in GAD65−/− (Soghomonian and Martin 1998). Our data
are thus consistent with GAD67 activity being selectively regu-
lated by GABA levels (Soghomonian and Martin 1998).
Slc38a1 Deﬁnes GABAergic Vesicular Dynamics and
Content
Slc38a1 inactivation impacts synaptic vesicle biology in GABAergic
neurons in 3 ways: (1) vesicle size is reduced, (2) vesicular GABA
content is reduced, while (3) vesicle density is increased.
Interestingly, many pre-synaptic factors have been identiﬁed to be
involved in deﬁning vesicular content by regulating vesicular ﬁlling
and/or vesicular recycling (Edwards 2007). The vesicular loading of
A B C
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Figure 7. Altered ocular dominance plasticity in Slc38a1−/− mice. Stimulus evoked ﬁring rates of excitatory (A,B) and inhibitory (D,E) units in response to stimulation
of contralateral (deprived) and ipsilateral (non-deprived) eyes with drifting gratings for slc38a1−/− (red) and Slc38a1+/+ (black) animals exposed to 4 days monocular
deprivation (MD) compared to untreated controls. For inhibitory units, Slc38a1−/− had signiﬁcantly higher contralateral eye evoked rates compared to Slc38a1+/+ (lin-
ear mixed model, pgenotype:unit type = 0.002; Comparison of least square means, pIN: ko vs. wt = 0.008). Contralateral bias was calculated based on responses to contralat-
eral vs. ipsilateral eye (C/(C + I)), with higher score indicating greater relative response to contralateral eye. (C) For excitatory units, monocular deprivation led to a
shift to lower contralateral bias, however, on group level, this shift was only signiﬁcant for Slc38a1+/+ animals (Slc38a1−/−: 0.495 ± 0.02, MD: 0.48 ± 0.02; Slc38a1+/+: 0.500 ±
0.012; MD: 0.43 ± 0.02, Linear mixed model, ptreatment = 0.04; pgenotype:treatment:unit type = 0.01; Comparison of least square means: pEX: ko vs. wt = 0.01; pEX,wt:control vs. MD = 0.004). F)
For inhibitory units, monocular deprivation led to a shift towards higher contralateral bias in Slc38a1+/+ animals (0.45 ± 0.03, pIN: wt: Control vs. wt = 0.02), while no such shift
took place in Slc38a1−/− animals (control: Slc38a1−/−: 0.50 ± 0.02; Slc38a1+/+:; MD: Slc38a1−/−: 0.52 ± 0.04; Slc38a1+/+: 0.59 ± 0.07, pwt: IN: control vs. MD = 0.02).
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e.g., dopamine depends on extracellular concentrations of dopa-
mine and on activation of tyrosine hydroxylase (Pereira and Sulzer
2012). We see reduced cytosolic concentrations of glutamate and
glutamine in GABAergic neurons. Our data corroborate that vesicu-
lar GABA is in steady state with extra-vesicular glutamate concen-
tration and that Slc38a1-mediated glutamine transport regulates
GABAergic quantal size (Mathews and Diamond 2003; Kanamori
and Ross 2006). The reduction in vesicle size may be due to
reduced transmitter amount and shrunken vesicles, as a linear
relationship has been demonstrated between quantal size and
vesicular volume (Karunanithi et al. 2002). Finally, the number of
synaptic vesicles may have been increased to overcome reduced
vesicular content and to sustain GABAergic neurotransmission.
Alternatively, a reduction in the vesicular GABA content and
dependence relatively more on re-uptake through GAT1 may have
increased the pool of releasing vesicles that may be smaller in size
(Steinert et al. 2006). Altogether, our data demonstrate that Slc38a1
activity has impact on GABAergic vesicular content.
Deletion of Slc38a1 Alters Cortical Processing and
Plasticity In vivo
Activity of PV+ interneurons is sufﬁcient to drive γ oscillations
(Cardin et al. 2009). Models of immature and mature PV+ inhibi-
tory networks show a development of γ oscillations from low
coherence and slower frequency in immature networks towards
higher γ frequency oscillations of greater coherence in mature
networks, reaching adult levels by the fourth week of life
(Doischer et al. 2008). Hence, the lower frequency γ oscillations
in Slc38a1−/− mice may reﬂect immaturity of PV+ inhibitory neu-
rons. The higher ﬁring activity observed in Slc38a1−/− inhibitory
neurons is in harmony with a compensation for lower GABA
quantal size as inhibitory neurons in general and PV+ neurons in
particular have strong self-inhibition (Pfeffer et al. 2013). Such
compensation may be insufﬁcient as Slc38a1−/− mice still show
slower γ oscillations and altered activity dependent plasticity.
The PV+ inhibitory neurons are established as key players
for critical period plasticity. In the visual cortex, this sub-class
of inhibitory neurons matures at the time of the critical period
and is assumed responsible for opening the period of plasticity.
Impaired GABAergic synaptic transmission is therefore likely to
affect reﬁnement of cortical circuits. Slc38a1−/− neurons have
impaired ocular dominance plasticity in response to MD during
the critical period compared to Slc38a1+/+ neurons. Our results
are similar to those from GAD65−/− mice, where impaired GABA
release delays opening of the critical period for ocular domi-
nance plasticity indeﬁnitely (Fagiolini and Hensch 2000), and
MD has no discernable effect on ocular dominance of the visual
cortex cells. This supports a role for Slc38a1 in GABA-
dependent plasticity of the developing cortex.
Conclusions
Slc38a1 is intrinsic for the deﬁning of the GABAergic vesicular
load and a key regulator of normal cortical development and
presynaptic inhibitory synaptic plasticity. As dysfunctional
GABA metabolism and signaling has been associated with sev-
eral neurological diseases such as in epilepsy, autism, schizo-
phrenia and anxiety (Soghomonian and Martin 1998; Lewis
et al. 2012), dysfunctional Slc38a1 activity may play a role in
their pathogenesis. Thus, further investigations are required to
reveal potential contribution of Slc38a1 to pathophysiology.
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Supplementary material is available at Cerebral Cortex online.
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